Correlation Between Tonix Pharmaceuticals and Akero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Akero Therapeutics, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Akero Therapeutics.

Diversification Opportunities for Tonix Pharmaceuticals and Akero Therapeutics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Tonix and Akero is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Akero Therapeutics go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and Akero Therapeutics

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the Akero Therapeutics. In addition to that, Tonix Pharmaceuticals is 2.69 times more volatile than Akero Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest  3,052  in Akero Therapeutics on September 1, 2024 and sell it today you would earn a total of  158.00  from holding Akero Therapeutics or generate 5.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  Akero Therapeutics

 Performance 
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Akero Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Tonix Pharmaceuticals and Akero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tonix Pharmaceuticals and Akero Therapeutics

The main advantage of trading using opposite Tonix Pharmaceuticals and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.
The idea behind Tonix Pharmaceuticals Holding and Akero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data